Related Experiment Videos
Results and expectations with image-integrated brainstem stereotactic biopsy
1Department of Neurological Surgery, University of Pittsburgh, Pennsylvania, USA.
Surgical Neurology
|June 1, 1995
Summary
Stereotactic brain stem biopsy offers a safe and effective method for diagnosing intrinsic brain tumors. This technique achieved a high diagnostic rate with minimal complications in a recent study.
Area of Science:
- Neurosurgery
- Neuropathology
- Oncology
Background:
- Histologic diagnosis of intrinsic brainstem tumors is challenging due to biopsy method controversies.
- Stereotactic brain stem biopsy has been underutilized due to concerns about morbidity and sample size.
Purpose of the Study:
- To evaluate the safety and efficacy of stereotactic biopsy for intrinsic brainstem lesions.
- To assess outcomes in patients undergoing CT-stereotactic guided brainstem biopsy.
Main Methods:
- Retrospective review of 40 consecutive patients undergoing stereotactic brainstem biopsy over 13 years.
- Utilized a dedicated CT-stereotactic operating room suite.
- Lesions included midbrain (n=20), pons (n=18), and medulla (n=2), approached via transthalamic or transcerebellar routes.
Main Results:
- Achieved a histologic diagnosis in 95% (38/40) of patients.
- No intraoperative hemorrhages occurred, confirmed by immediate post-biopsy CT scans.
- Low morbidity rate of 2.5% (1 patient with transient diplopia), with no mortality.
Conclusions:
- Stereotactic biopsy is a safe and effective method for intrinsic brainstem lesions, comparable to supratentorial biopsies.
- High accuracy and low risk achieved using high-resolution imaging, appropriate trajectories, and specialized neuropathology.
- Biopsy results enabled tailored management strategies for patients with brainstem tumors.